32 Results for "

DM4

" in MedChemExpress (MCE) Product Catalog:
Products (32)

32 Results for "DM4" in MCE Product Catalog:

5
5 Cited Publications
Cat. No.: HY-12454
CAS No.: 796073-69-3
Purity:  99.64%
Synonyms: Ravtansine
Research Areas:  

Cancer

DM4 is is an antitubulin agent that inhibit cell division. DM4 can be used in the preparation of antibody agent conjugate.
3
3 Cited Publications
Cat. No.: HY-132258A
CAS No.: 1453084-37-1
Purity:  99.71%
Synonyms: IMGN853 (solution)
Research Areas:  

Cancer

Mirvetuximab soravtansine (IMGN853) solution is an anti-folate receptor α (FRα) antibody drug-conjugate (ADC) consisting of the cytotoxic maytansinoid, DM4, covalently linked to the humanized monoclonal antibody M9346A, and the drug-linker conjugate for ADC is sulfo-SPDB-DM4 (HY-101141). Mirvetuximab soravtansine selectively binds to folate receptor 1 (FOLR1). Mirvetuximab soravtansine has an anti-proliferative effect via growth arrest and augmented DNA damage .
3
3 Cited Publications
Cat. No.: HY-12460
CAS No.: 1626359-62-3
Purity:  98.14%
Research Areas:  

Cancer

SPDB-DM4 is a agent-linker conjugate for ADC by using the maytansinebased payload (DM4, a tubulin inhibitor) via a SPDB linker, exhibiting potent anti-tumor activity.
1
1 Cited Publications
Cat. No.: HY-P99542
CAS No.: 2254086-60-5
Synonyms: SAR-408701; HuMAb2-3-SPDB-DM4
Tusamitamab ravtansine (SAR-408701) is a targeted ADC against tumor cells expressing CEACAM5, composed of a humanized anti-CEACAM5 monoclonal antibody covalently linked to the potent cytotoxic agent, maytansinoid DM4 (HY-12454), via a cleavable linker. Tusamitamab ravtansine has an average drug-to-antibody ratio (DAR) of 3.8 .
1
1 Cited Publications
Cat. No.: HY-101141
CAS No.: 1626359-59-8
Purity:  99.81%
Research Areas:  

Cancer

sulfo-SPDB-DM4 is a agent-linker conjugate for ADC by using the maytansinebased payload (DM4, an antitubulin agent) via the sulfo-SPDB linker.
1
1 Cited Publications
Cat. No.: HY-148818
CAS No.: 890654-03-2
Purity:  99.03%
Target:  

ADC Payloads

Research Areas:  

Others

S-Me-DM4 is a metabolite of DM4 S-methylated by intracellular enzyme. DM4 (HY-100503) is a microtubule-depolymerizing maytansinoid with strong cytotoxicity. DM4 can be used as an ADC Cytotoxin molecule .
1
1 Cited Publications
Cat. No.: HY-P99493
CAS No.: 868747-45-9
Synonyms: IMGN242; huC242-DM4
Cantuzumab ravtansine (IMGN242; huC242-DM4), an ADC, is a humanized monoclonal antibody, huC242, covalently linked via a disulfide bond to DM4 (HY-12454). Cantuzumab ravtansine has broad antitumor efficacy against a range of CanAg-positive human tumor xenografts .
Cat. No.: HY-141606
CAS No.: 1375258-01-7
Purity:  99.36%
Synonyms: BAY 94-9343
Anetumab ravtansine (BAY 94-9343) is a selective and highly potent antibody-drug conjugate (ADC) to target maytansinoid tubulin. Anetumab ravtansine consists of a human anti-mesothelin antibody conjugated to the maytansinoid tubulin inhibitor DM4. Anetumab ravtansine shows antitumor efficacy correlated with the amount of mesothelin expressed in patient-derived xenograft tumor models .
Cat. No.: HY-141607
CAS No.: 1238517-16-2
Purity:  99.09%
Synonyms: BT-062; nBT062-DM4

Research Areas:  

Cancer

Indatuximab ravtansine (BT-062) is an antibody-drug conjugate (ADC) based on a murine/human chimeric form of B-B4 (specific for CD138), linked to the maytansinoid agent DM4 by disulphide bonds. Indatuximab ravtansine shows anti-tumor activities .
Cat. No.: HY-126494
CAS No.: 1228105-52-9
Purity:  96.86%
Research Areas:  

Cancer

DM4-SMCC is a agent-linker conjugate for ADC with antitumor activity by using DM4 (an antitubulin agent), linked via the non-cleavable SMCC linker .
Cat. No.: HY-130082
CAS No.: 796073-68-2
Purity:  99.99%
Research Areas:  

Cancer

DM4-SMe is a metabolite of antibody-maytansin conjugates (AMCs) and a tubulin inhibitor, and also a cytotoxic moiety of antibody-drug conjugates (ADCs), which can be linked to antibody through disulfide bond or stable thioether bond. DM4-SMe inhibits KB cells with an IC50 of 0.026 nM. DM4-SMe is a highly toxic metabolite that can be oxidized and detoxified by human liver microsomes .
Cat. No.: HY-164669
Research Areas:  

Cancer

ADC Control Human IgG1-DM4 is an isotype control of ADC Human IgG1-DM4. The antibody portion is Human IgG1 kappa, Isotype Control (HY-P99001), and the drug-linker conjugate for ADC is SPDB-DM4 (HY-12460).
Cat. No.: HY-100503
CAS No.: 799840-96-3
Target:  

ADC Payloads

Research Areas:  

Cancer

Maytansinoid DM4 is a thiol-containing maytansine derivative with highly potent cytotoxicity. Maytansinoid DM4 can be used as a cytotoxic moiety of ADC .
Cat. No.: HY-12454S
Purity:  99.11%
DM4-d6 is deuterium labeled DM4. DM4 is is an antitubulin agent that inhibit cell division. DM4 can be used in the preparation of antibody agent conjugate.
Cat. No.: HY-150363
ADC Control Human IgG1-sulfo-SPDB-DM4 is an antibody-drug conjugate (ADC) and can inhibit tubulin polymerization. The antibody portion is Human IgG1 kappa, Isotype Control (HY-P99001), and the drug-linker conjugate for ADC is sulfo-SPDB-DM4 (HY-101141) .
Cat. No.: HY-126493
DM4-SPDP is a Drug-Linker Conjugates for ADC. DM4-SPDP consists of the ADC cytotoxin DM4 (HY-12454) and a linker SPDP (HY-100216). DM4-SPDP can be used for synthesis of ADCs .
Cat. No.: HY-143985S
Maytansinoid DM4 impurity 5-d6 is the deuterium labeled Maytansinoid DM4 impurity 5 .
Cat. No.: HY-143992S
Maytansinoid DM4 impurity 2-d6 is the deuterium labeled Maytansinoid DM4 impurity 2 .
Cat. No.: HY-143993S
Maytansinoid DM4 impurity 3-d6 is the deuterium labeled Maytansinoid DM4 impurity 3 .
Cat. No.: HY-128954
CAS No.: 1461704-01-7
Sulfo-PDBA-DM4 is a agent-linker conjugate composed of a potent a tubulin inhibitor DM4 and a linker Sulfo-PDBA to make antibody agent conjugate (ADC). Sulfo-PDBA is a gluthatione cleavable linker.